Recently, a novel anti-obesity mechanism of SGLT2 inhibition was reported, where EMPA treatment decreased adipose macrophage infiltration and increased energy expenditure in a model of diet-induced obesity [41]. This evidence concerns the gene SLC5A2 and obesity disorder.